ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 759857 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 759857; 2) Community: the network communities that were significantly associated with the response to NSC 759857; 3) Molecule: the relationships between components within communities and NSC 759857; 4) MDR: the compounds that were significantly associated with the NSC 759857.

NSC Compound Enrichment Correlation
NSC 681638 Camptothecin Derivative 0.00736331140329775 0.60956485
NSC 700584 [1,4,2,3]-Dithiaselenoca[5,6-d:7,8-d']diimidazole- 2,9-diselone, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- 0.00736331140329775 -0.10428615
NSC 714365 Null 0.00736331140329775 0.28573097
NSC 715223 Null 0.00736331140329775 0.13292949
NSC 744116 Null 0.00736331140329775 -0.056900574
NSC 753221 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline 0.00736331140329775 0.25759547
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.00736331140329775 0.52380301
NSC 682866 Ethanone, 1-[7-(4-chlorophenyl)-5,6-dihydro-9-methyl- 7H-benzo[h]thiazolo[2,3-b]quinazolin-10-yl]- 0.00783051864107159 -0.027868527
NSC 116789 Acovenoside B 0.0078305186410717 0.31433096
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.0078305186410717 0.44137801
Total:54  Current:10    [First] [Prev] [Next] [Last]